Alteration of early haematopoietic development is thought to be responsible for the onset of immature leukemias and lymphomas. We have previously demonstrated that TaxHTLV-1 interferes with ß-selection, an important checkpoint of early thymopoiesis, indicating that human T-cell leukemia virus type 1 (HTLV-1) infection has the potential to perturb thymic human αβ T-cell development. To verify that inference and to clarify the impact of HTLV-1 infection on human T-cell development, we investigated the in vivo effects of HTLV-1 infection in a “Human Immune System” (HIS) Rag2-/-γc-/- mouse model. These mice were infected with HTLV-1, at a time when the three main subpopulations of human thymocytes have been detected. In all but two inoculated mice, the HTLV-1 provirus was found integrated in thymocytes; the proviral load increased with the length of the infection period. In the HTLV-1-infected mice we observed alterations in human T-cell development, the extent of which correlated with the proviral load. Thus, in the thymus of HTLV-1-infected HIS Rag2-/-γc-/- mice, mature single-positive (SP) CD4+ and CD8+ cells were most numerous, at the expense of immature and double-positive (DP) thymocytes. These SP cells also accumulated in the spleen. Human lymphocytes from thymus and spleen were activated, as shown by the expression of CD25: this activation was correlated with the presence of tax mRNA and with increased expression of NF-kB dependent genes such as bfl-1, an anti-apoptotic gene, in thymocytes. Finally, hepato-splenomegaly, lymphadenopathy and lymphoma/thymoma, in which Tax was detected, were observed in HTLV-1-infected mice, several months after HTLV-1 infection. These results demonstrate the potential of the HIS Rag2-/-γc-/- animal model to elucidate the initial steps of the leukemogenic process induced by HTLV-1. Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus responsible for the development of Adult T cell Leukemia, an aggressive malignant lymphoproliferation that occurs several decades after viral exposure in some individuals infected when neonates via breastfeeding. Here, we used mice that were humanized by transplantation of human hematopoietic stem cells isolated from cord blood. Such an animal model may reproduce key aspects of in vivo infection with HTLV-1 and improve the understanding of the early steps of the leukemogenic process. These humanized mice when inoculated with HTLV-1 were indeed productively infected, as shown by the detection and the expression of the provirus in human cells. We observed that T-cell development in the thymus of these mice was profoundly altered, as ascertained by the increased proliferation of activated mature T lymphocytes that accumulated in the thymus as well as in the spleen. These alterations of human thymic T-cell development may be linked to the development of ATL–like pathologies. These results show that this humanized mouse model provides an invaluable tool not only to study the early stages of the infection leading to the development of malignant lymphoproliferations, but also to design new therapeutic approaches.